Guerri-GuttenbergRCastillaRCaoGAzzatoFAmbrosioGMileiJ. Coronary intimal thickening begins in fetuses and progresses in pediatric population and adolescents to atherosclerosis. Angiology. [Published ahead of print 14 May 2019]. doi:10.1177/0003319719849784
2.
QuYZhangFYangJet al.Clinical characteristics and outcomes in Asian patients with premature coronary artery disease: insights from the Focus registry. Angiology. 2019;70(6):554–60.
3.
IcenYKKocASSumbulHE. Coronary artery disease severity is associated with abdominal aortic intima-media thickness in patients with non-ST-segment elevation myocardial infarction. Angiology. 2019;70(6):561–6.
4.
WuSLiuWMaQet al.Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optimal coherence tomography. Angiology. 2019;70(6):539–46.
5.
YuFLiJHuangQCaiH.Increased peripheral blood visfatin concentrations may be a risk marker of coronary artery disease: a meta-analysis of observational studies. Angiology. 2018;69(9):825–34.
6.
NazSHSandhuQSHAkhtarAZafarUKhalidASaeedM. Serum levels of visfatin and interleukin-6 in non-obese versus obese men with coronary artery disease. J Coll Physicians Surg Pak. 2017;27(2):71–4.
7.
DarabiFAghaeiMMovahedianAElahifarAPourmoghadasASarrafzadeganN. Association of serum microRNA-21 levels with visfatin, inflammation, and acute coronary syndromes. Heart Vessels. 2017;32(5):549–57.
8.
GrzywoczPMizia-StecKWybraniecMChudekJ. Adipokines and endothelial dysfunction in acute myocardial infarction and the risk of recurrent cardiovascular events. J Cardiovasc Med (Hagerstown). 2015;16(1):37–44.
9.
BrianaDDMalamitsi-PuchnerA. Visfatin: a risk marker for a plethora of diseases in adults and infants [published online ahead of print]. Angiology. 2018:3319718807616. doi:10.1177/0003319718807616